8 Result: Accenture
What Wall Street Expects From Accenture, Acuity, and McCormick as Earnings Near
September 27th, 2026
LAS VEGAS, NV / CRWE PRESS RELEASE / September 27, 2026 - Notable companies slated to report financial results on Thursday, October 1, include: Accenture plc (NYSE: ACN), a global professional services firm specializing in consulting, techno. Read more
Ahead of Earnings: Cintas, Accenture, and Darden Restaurants in the Spotlight
December 14th, 2025
Las Vegas, NV / CRWE PRESS RELEASE / December 14, 2025 - Several companies are scheduled to release their financial results on Thursday, December 18, including: Cintas Corporation (Nasdaq: CTAS), a provider of corporate identity uniforms and facil. Read more
Wall Street Eyes Accenture, TD SYNNEX, Concentrix Ahead of Earnings
September 22nd, 2025
LAS VEGAS, NV / CRWE PRESS RELEASE / September 22, 2025 - Several notable companies are set to release their financial results on Thursday, September 25, including: Accenture plc (NYSE: ACN), a global consulting and IT services leader, will announ. Read more
Earnings Countdown: Accenture, NIKE, and Micron Technology Brace for Reports
March 16th, 2025
Several high-profile companies are set to announce their latest financial results on Thursday, March 20, including: Accenture plc (NYSE: ACN), a global consulting and IT services firm, will report its second-quarter fiscal 2025 earnings before the. Read more
Eyes on the Numbers: Accenture, FedEx, and FactSet's Earnings Preview
December 16th, 2023
On Tuesday, December 19, several prominent companies are scheduled to unveil their financial performance, including: Accenture plc (NYSE: ACN), a global professional services firm, is set to release its first-quarter fiscal 2024 financial results . Read more
Setback for BrainStorm Cell Therapeutics; Accenture Posts Mixed Results
September 28th, 2023
BrainStorm Cell Therapeutics Inc. (Nasdaq: BCLI), a biotechnology company that specializes in developing innovative stem cell therapies for neurodegenerative diseases, faced a setback as the U.S. Food and Drug Administration's Cellular, Tissue, and G. Read more
Earnings Spotlight: Accenture, NIKE, and Jabil on the Horizon
September 24th, 2023
On Thursday, September 28, a number of companies are scheduled to announce their financial results, including: Accenture plc (NYSE: ACN), a global consulting and professional services firm, is set to announce its fourth-quarter and full-year fisca. Read more
Evaxion Biotech: Promising EVX-01 Clinical Data; Celsius, Accenture, Five Below: PT Raised
June 04th, 2023
Evaxion Biotech A/S (Nasdaq: EVAX) announced encouraging findings from its EVX-01 Phase 1 clinical trial, which assessed the safety and effectiveness of EVX-01 in combination with a checkpoint inhibitor for metastatic melanoma patients. Acco. Read more
Want To Find Some News?
News By Industries
Recent Post
-
DOT, DoW, DHS Join Forces to Protect Southern Border Airspace
October 16th, 2026FTC Sues Ticket Broker Over Unlawful Tactics Used to Buy Millions of Tickets to Popular Live Events
October 15th, 2026October 15th, 2026FDA Approves First Treatment for Certain People With BCG-Unresponsive Bladder Cancer
October 14th, 2026U.S. Treasury Announces Record Enforcement Actions Against Bank of America
October 14th, 2026
Member Login